HomeLatest NewsAIIMS panel gives nod for human clinical trials of indigenous vaccine candidate...

AIIMS panel gives nod for human clinical trials of indigenous vaccine candidate COVAXIN

The AIIMS Ethics Committee has given its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate COVAXIN. AIIMS is likely to begin the exercise by enrolling healthy volunteers from Monday.

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research for conducting phase I and II human trials of COVAXIN. In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.

Also Read: Coronavirus vaccine update: ICMR-Bharat Biotech Covaxin test results to be released on August 15

Healthy volunteers having no comorbid conditions and without a history of COVID-19, aged more than 18 years and less than 55 years, would be eligible to participate in the randomised, double-blind, placebo-controlled clinical trial.

36 COMMENTS

  1. You can protect yourself and your dearest close being wary when buying prescription online. Some druggist’s websites operate legally and offer convenience, reclusion, bring in savings and safeguards over the extent of purchasing medicines. http://playbigbassrm.com/

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img